- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03629548
Comparing Foley Catheter Balloon With Early Amniotomy for Induction of Labor at Term
February 1, 2021 updated by: Ahmet Eser, Zeynep Kamil Maternity and Pediatric Research and Training Hospital
Comparing Combined Foley Catheter Balloon and PGE2 Vaginal Ovule With Early Amniotomy and PGE2 for Induction of Labor at Term: A Randomized Study
This study evaluates the intervention for induction of labor with low bishop scores .
One group will be induced by transcervical Foley catheter balloon and vaginal PGE2 and other group will be induced by early amniotomy and PGE2 vaginal ovule for induction of labor at term.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
An unfavorable cervix during induction decreases the success rate of labor induction and vaginal delivery.
Therefore it is required to apply cervical ripening methods for unfavorable cervices.
Application of transcervical Foley catheter is an effective mechanical method and has the advantages of lower cost and lowest rate of fetal heart rate changes due to tachysystole compared with PGE1 and PGE2.
Despite the advantages of mechanical methods, PGE1 and PGE2 are reported to be more effective than mechanical methods to achieve vaginal delivery within 24 hours.
Although there are a lot of studies comparing PGE1, PGE2 and transcervical Foley balloon catheter separately and PGE1 combined with transcervical Foley balloon catheter, less is known about combined usage of PGE2 and transcervical Foley balloon catheter.
Early amniotomy is another effective method to ripen cervix.
we aim to evaluate which method is superior to another.
Study Type
Interventional
Enrollment (Actual)
250
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Uskudar
-
Istanbul, Uskudar, Turkey, 34668
- zeynep kamil education and research hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- singleton pregnancy,
- gestational age ≥37 weeks,
- intact membranes,
- cephalic presentation,
- bishop score ≤5,
- had obstetrical indications for induction of labor,
- had less than three uterine contractions in every 10 minutes.
Exclusion Criteria:
- Patients who had contraindications for vaginal delivery,
- previous uterine surgery,
- fetal malpresentation,
- multifetal pregnancy,
- more than three contractions in 10 minutes,
- contraindications to prostaglandins,
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: early amniotomy plus dinoprostone
10 mg dinoprostone vaginal ovul will be inserted to the posterior fornix.
Early amniotomy will be done in the early active phase of labor for early amniotomy group ( half of participants) when the cervix will be dilated 3 cm using the amniotomy hook.
|
10 mg PGE2 vaginal ovul will be inserted to the posterior fornix.
Early amniotomy will be done in the early active phase of labor for early amniotomy group ( half of participants) when the cervix will be dilated 3 cm using the amniotomy hook.
|
|
EXPERIMENTAL: foley balloon catheter plus dinoprostone
an 18-F Foley catheter which filling with 30 mL of saline solution will be placed into the cervix and after placement of balloon catheter 10 mg dinoprostone vaginal ovul will be inserted to the posterior fornix
|
an 18-F Foley catheter which filling with 30 mL of saline solution will be placed into the cervix and after placement of balloon catheter 10 mg PGE2 vaginal ovul will be inserted to the posterior fornix
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
induction-to- delivery time
Time Frame: from the beginning of induction until the labor
|
the length of time between the beginning of induction and the end of labor
|
from the beginning of induction until the labor
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
induction-to-active phase of labor time
Time Frame: from the beginning of induction until the labor
|
the length of time between the beginning of induction and the onset of labor
|
from the beginning of induction until the labor
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
August 15, 2018
Primary Completion (ACTUAL)
September 15, 2019
Study Completion (ACTUAL)
October 1, 2019
Study Registration Dates
First Submitted
March 27, 2018
First Submitted That Met QC Criteria
August 11, 2018
First Posted (ACTUAL)
August 14, 2018
Study Record Updates
Last Update Posted (ACTUAL)
February 4, 2021
Last Update Submitted That Met QC Criteria
February 1, 2021
Last Verified
February 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- 48
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Induced Vaginal Delivery
-
Faculty Hospital Kralovske VinohradyCompletedPotential of Vojta's Reflex Locomotion as a Pre/Induction Method for Uterine Activity: a Pilot StudyInduced Vaginal DeliveryCzechia
-
Stanford UniversityCompleted
-
Karolinska InstitutetCompletedInduced Vaginal DeliverySweden
-
The University of Texas Medical Branch, GalvestonCompletedInduced Vaginal DeliveryUnited States
-
University of LiverpoolLiverpool Women's NHS Foundation TrustCompletedInduced Vaginal DeliveryUnited Kingdom
-
University of AlexandriaCompleted
-
Rambam Health Care CampusUnknownInduced Vaginal Delivery
-
Montefiore Medical CenterTerminated
-
Hurley Medical CenterRecruitingInduced; Birth | Induced Vaginal DeliveryUnited States
-
Western Galilee Hospital-NahariyaCompleted
Clinical Trials on early amniotomy
-
University of Alabama at BirminghamCompletedLabor Induction | Preterm PregnancyUnited States
-
University of PennsylvaniaWithdrawn
-
University Tunis El ManarCompletedLabor, Induced | AmniotomyTunisia
-
The University of Texas Medical Branch, GalvestonCompletedLabor Induction | Early AmniotomyUnited States
-
Assiut UniversityCompletedProlonged Labor
-
Assiut UniversityCompleted
-
Assuta Ashdod HospitalRambam Health Care Campus; Wolfson Medical Center; The Baruch Padeh Medical Center...TerminatedInduction of Labor Affected Fetus / NewbornIsrael
-
Menoufia UniversityCompleted
-
Universidade Federal de PernambucoCompletedMuscle Weakness | Intensive Care Unit SyndromeBrazil
-
Cliniques universitaires Saint-Luc- Université...CompletedCritical IllnessBelgium